Sign In
Buy IRMD
$91.12
+1.26 (+1.40%)
At Close: Jun 03, 2026
IRADIMED CORPORATION Named to Fortune's 100 Fastest Growing Companies List for 2024
08:30am, Monday, 04'th Nov 2024
WINTER SPRINGS, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune's 100 Fastest Growing Companies for 2024. Iradimed is
IRADIMED CORPORATION (IRMD) Q3 2024 Earnings Call Transcript
07:52pm, Thursday, 31'st Oct 2024
IRADIMED CORPORATION. (NASDAQ:IRMD ) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - CFO Conference C
IRadimed (IRMD) Beats Q3 Earnings and Revenue Estimates
10:26am, Thursday, 31'st Oct 2024
IRadimed (IRMD) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.43 per share a year ago.
WINTER SPRINGS, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30,
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
04:05pm, Thursday, 24'th Oct 2024
WINTER SPRINGS, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the market ope
IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
04:05pm, Thursday, 03'rd Oct 2024
WINTER SPRINGS, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devic
IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
04:30pm, Tuesday, 10'th Sep 2024
WINTER SPRINGS, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devi
IRADIMED CORPORATION (IRMD) Q2 2024 Earnings Call Transcript
06:17pm, Saturday, 03'rd Aug 2024
IRADIMED CORPORATION (NASDAQ:IRMD ) Q2 2024 Results Conference Call August 1, 2024 12:00 PM ET Company Participants Roger Susi - President and Chief Executive Officer Matt Garner - Controller Conferen
IRadimed (IRMD) Surpasses Q2 Earnings and Revenue Estimates
10:50am, Thursday, 01'st Aug 2024
IRadimed (IRMD) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.36 per share a year ago.
WINTER SPRINGS, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three and six months ended June 30, 2024.
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
08:30am, Thursday, 25'th Jul 2024
Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market o
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
08:30am, Friday, 07'th Jun 2024
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devic
IRADIMED CORPORATION (IRMD) Q1 2024 Earnings Call Transcript
01:27pm, Saturday, 04'th May 2024
IRADIMED CORPORATION (NASDAQ:IRMD ) Q1 2024 Results Conference Call May 2, 2024 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - Chief Financial Officer
WINTER SPRINGS, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months ended March 31, 2024. The Comp
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
04:05pm, Thursday, 25'th Apr 2024
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market op
